| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $223.6M | -1.1% | +122.4% |
| R&D Expense | $15.7M | +25.6% | +60.2% |
| SG&A Expense | $27.9M | -2.7% | +11.8% |
| Operating Income | $28.7M | -20.1% | +50.7% |
| Interest Expense | $17.7M | +7.7% | +82.8% |
| Pre-tax Income | -$563K | -103.3% | -104.6% |
| Income Tax | $1.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $133.6M | +30.8% | -24.4% |
| Accounts Receivable | $114.4M | +1.4% | +149.3% |
| Inventory | $81.9M | -6.9% | +9.4% |
| Current Assets | $423.6M | +9.8% | +21.9% |
| Total Assets | $1.30B | +2.5% | +59.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $116.0M | — | — |
| Capital Expenditures | $25.5M | — | — |
| Investing Cash Flow | -$23.5M | — | — |
| Financing Cash Flow | -$1.1M | — | — |
| Free Cash Flow | $90.5M | — | — |
| -67.2% |
| -10.2% |
| Net Income | -$1.9M | -115.1% | -118.2% |
| EPS (Basic) | -$0.01 | -110.0% | -112.5% |
| EPS (Diluted) | -$0.01 | -111.1% | -112.5% |
| $243.7M |
| +8.0% |
| +151.2% |
| Long-term Debt | $833.0M | +0.1% | +42.7% |
| Total Liabilities | $1.19B | +2.4% | +56.7% |
| Stockholders' Equity | $107.0M | +4.1% | +102.9% |